Micro-RNAs in cognition and cognitive disorders: Potential for novel biomarkers and therapeutics
- 1 March 2016
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 104, 1-7
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Alteration of the microRNA network during the progression of Alzheimer's diseaseEMBO Molecular Medicine, 2013
- miR-132/212 Knockout Mice Reveal Roles for These miRNAs in Regulating Cortical Synaptic Transmission and PlasticityPLOS ONE, 2013
- miRNA-132: a dynamic regulator of cognitive capacityBrain Structure and Function, 2012
- Blood serum miRNA: Non-invasive biomarkers for Alzheimer's diseaseExperimental Neurology, 2012
- Roles for MicroRNAs in Conferring Robustness to Biological ProcessesCell, 2012
- microRNA‐34c is a novel target to treat dementiasThe EMBO Journal, 2011
- Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cellsMolecular Psychiatry, 2011
- Brain and Blood microRNA Expression Profiling of Ischemic Stroke, Intracerebral Hemorrhage, and Kainate SeizuresJournal of Cerebral Blood Flow & Metabolism, 2009
- Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem CellsCell, 2008
- The relationship between non‐protein‐coding DNA and eukaryotic complexityBioEssays, 2007